Patient Power
Some patients who are diagnosed with myelofibrosis, a rare and chronic blood cancer that affects the bone marrow, also have a gene mutation called Janus kinase (JAK2). Abhinav Deol, M.D., hematologist, medical oncologist, and member of the Bone Marrow and Stem Cell Transplant, Hematology Oncology and Multiple Myeloma and Amyloidosis Multidisciplinary Teams at Karmanos, what causes the JAK2 mutation and therapies that target the mutation.
Read the article here.